EDITAS MEDICINE, INC. : EDIT Stock Price | US28106W1036 ... A rank of 33 means that 67% of stocks appear more favorable to our system. investment rating. Case 2: Editas stock rises by 5% or more in a week. In the short term (2weeks), EDIT's stock price should outperform the market by 1.60%.During that period the price should oscillate between -10.24% and +13.07%.. EDIT STOCK FORECAST 17 DECEMBER 2021! EDITSTOCK news ... A company's earnings reviews provide a brief indication of a stock's direction in the short term, where in the case of Editas Medicine Inc. 1 upward and no downward comments were posted in the last 7 days. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. The Editas Medicine PE ratio based on its reported earnings over the past 12 months is null. A Side-by-Side View lists Calls on the left and Puts on the right. What this means: InvestorsObserver gives Editas Medicine (EDIT) an overall rank of 33, which is below average. The company's revenue is forecast to drop by -79.00% over what it did in 2021. (NYSE: BABA) Alibaba's current Earnings Per Share (EPS) is $7.18. ( 69.11% upside) Analyst Consensus: Buy. The stock's last reported lowest price was 35.06. Frankfurt Stock Market & Finance report, prediction for the future: You'll find the Editas Medicine share forecasts, stock quote and buy / sell signals below.According to present data Editas Medicine's 8EM shares and potentially its market environment have been in a bullish cycle in the last 12 months . Date Range. A high-level overview of Editas Medicine, Inc. (EDIT) stock. Also, this average forecast of $65.2 represents a 38.14% increase from the past average forecast of $47.2, 6 months ago from 10 wall street analysts. A company's earnings reviews provide a brief indication of a stock's direction in the short term, where in the case of Editas Medicine Inc. 1 upward and no downward comments were posted in the last 7 days. Find the latest Editas Medicine, Inc. EDIT analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Complete Editas Medicine Inc. stock information by Barron's. View real-time EDIT stock price and news, along with industry-best analysis. $52.07. Editas Medicine (EDIT) Stock Return: AI Predicts EDIT Average and Excess Return After a Fall or Rise. The Editas Medicine, Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. As an investor, you can get an idea of where the stock is trending by the forecast and beta. The inherited condition is the most common cause of genetic childhood blindness, Editas . holmes.michael.p Nov 9. Editas Medicine 's earnings in 2021 is -$213,565,000.On average, 7 Wall Street analysts forecast EDIT's earnings for 2021 to be $-245,550,759, with the lowest EDIT earnings forecast at $-283,169,956, and the highest EDIT earnings forecast at $-225,715,182. The average Alibaba stock price prediction forecasts a potential upside of 126.14% from the current BABA share price of $122.24. However, it does not forecast the overall direction of its price. In a nutshell, if Editas Medicine's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. Written By Chung Hieu Bui. EDIT Stock Trend. It's tough to imagine a world where biotechnology advances but leaves CRISPR Therapeutics behind. The shares last closed at $27.72. The high for today is $73.03 and the low is $65.95. The resulting number helps traders determine whether the premium of an option is "fair" or not. View analysts' price targets for Editas Medicine or view top-rated stocks among Wall Street analysts. It operates through the developing and commercializing genome editing technology segment. Forecast Period: 2021-2026 . So, if you're looking for a reason to buy, don't put too much weight on it being oversold. However, looking at the P/S for Editas is . Now that you know more about Editas Medicine Inc stands, let's learn more about the future of the company. CRISPR (pronounced "crisper") is an acronym for "Clustered, Regularly Interspaced, Short Palindromic Repeats," and refers to a recently developed gene editing technology that can revise, remove, and . holmes.michael.p Nov 9. Editas Medicine Inc. (EDIT) estimates and forecasts , 1W Long. The average price target represents a -8.74% change from the last price of $65.53. 32.51 Day Range 33.81. Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing. Over the next 52 weeks, Editas Medicine Inc has on average historically risen by 20.1 % based on the past 5 years of stock performance. Editas set for a homerun. Beta is calculated using regression analysis. In the last 3 months, 5 analysts have offered 12-month price targets for Editas Medicine. EDIT. Signals & Forecast. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. EDIT : Editas Medicine stock forecast by Wall Street Analysts. Given the current short-term trend, the stock is expected to fall -43.23% during the next 3 months and, with a 90% probability hold a price between $9.06 and $21.32 at the end of this 3-month period. Case 2: Editas stock rises by 5% or more in a week. EDIT stock forecast Our latest prediction for Editas Medicine Inc's stock price was made on the March 2, 2021 when the stock price was at 45.69$.. The company has an average price target of $65.2 with a high of $80 . Price Target. Some of the losses seen by insiders who purchased US$1.4m worth of Editas Medicine, Inc. (NASDAQ:EDIT) shares over the past year were recovered after the stock increased by 6.8% over the past week.The purchase, however, has proven to be a pricey bet, with losses currently totalling US$250k. As a result, EDIT stock is up as much as 5% in morning trading. Editas Stock Set to Fly Higher on this Technology One of our strategies for investing in high-growth stocks is to look for companies with cutting-edge technologies in emerging fields. 11/10/21 : Q3 2021 Earnings Release (Projected) 11/12/21 : Society for immunotherapy of cancer meeting - abstract no #: 191: 03/08/22 : FY 2021 Earnings Release (Projected) Based on 5 Wall Street analysts offering 12 month price targets for Editas Medicine in the last 3 months. Editas Medicine Inc Stock Forecast. Editas Medicine is a pioneer in gene editing technology. Bottom Line: CRISPR Stock Forecast. View EDIT's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. ( 69.11% upside) Analyst Consensus: Buy. $1.28 (7.64%) Wall Street Stock Market & Finance report, prediction for the future: You'll find the Editas Medicine share forecasts, stock quote and buy / sell signals below.According to present data Editas Medicine's EDIT shares and potentially its market environment have been in bearish cycle last 12 months (if . Jan. 26, 2021, 06:30 AM. Due to the stock's strong downtrend, it may remain oversold for a while. Is the price forecast for Editas stock higher over the subsequent month after Case 1 or Case 2? Their forecasts range from $20.00 to $86.00. Get the latest Editas Medicine, Inc. EDIT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Editas Medicine is selling for under 35.35 as of the 22nd of November 2021; that is -2.54 percent decrease since the beginning of the trading day. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Over the past year the S&P 500 is up 17.69% while EDIT has risen 67.25%. $31.18. EDIT. $29.26 $0.25 0.9%. 33% vs Avg. This is a small company with massive potential. EDIT. Previous Close. $18.03. Overall, given the vast institutional interest, its stable financial position, and the success of similar gene therapeutics in the industry, Editas is a risky but high-reward stock to buy. The company's revenue is forecast to drop by -79.00% over what it did in 2021. Editas Medicine, Inc. is a clinical-stage gene editing company. Editas Medicine (NASDAQ: EDIT) is quickly becoming one of the hottest biotech and gene therapy stocks on the market. , 1W Long. Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that . Yesterday, biotech company Editas Medicine (NASDAQ:EDIT) shared positive preclinical results for one of its cancer treatments. Editas Medicine, Inc () Stock Market info Recommendations: Buy or sell Editas Medicine stock? Exploring Editas Medicine (NASDAQ:EDIT) stock? After losing some value lately, a hammer chart pattern has been formed for Editas (EDIT), indicating that the stock has found support. . [9/30/2021] Editas Medicine (EDIT) Stock Price Forecast: AI Forecasts EDIT Stock Price To Be Around $53.60 In A Month (Up 26%) 2021-09-30. APVO Stock Forecast, Price Targets and Analysts Predictions - TipRanks. EDIT Stock Continues Its Dive. Intraday data delayed at least 15 minutes or per . To hit the forecast high, the stock's price needs a -23.31% plunge from its current level, while the stock would need to tank 64.99% for it to hit the projected low. EDIT Stock Analysis Overview. Side-by-Side View. It is also a measure of investors' predictions about future volatility of the underlying stock. Last: The last traded price for the options contract. Is the price forecast for Editas stock higher over the subsequent month after Case 1 or Case 2? According to 12 analysts, the average rating for EDIT stock is "Buy." The 12-month stock price forecast is 52.07, which is an increase of 69.11% from the latest price. High volatility in Editas Medicine, Inc stock price on Thursday which ended trading at $27.83The Editas Medicine, Inc stock price fell by -7.05% on the last . View real-time stock prices and stock quotes for a full financial overview. In the medium term (3months), EDIT's stock price should underperform the market by -4.00%. $52.07. High volatility in Editas Medicine, Inc stock price on Thursday which ended trading at $27.83The Editas Medicine, Inc stock price fell by -7.05% on the last . EDIT | Complete Editas Medicine Inc. stock news by MarketWatch. As is evident from the statistics, the company's shares have fallen -12.05 percent over the past six months and at a -79.80% annual growth rate that is well below the . Editas looks ready to launch on the weekly with a bounce off support and 3x rsi hidden bullish divergence. Editas Medicine's implied volatility exposes the market's sentiment of Editas Medicine stock's possible movements over time. The bears made the stock sink to a new 52-week low. Get the latest Editas Medicine, Inc. EDIT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Turning out attention to how the Editas Medicine Inc. stock has performed in comparison to its peers in the industry, here's what we find: EDIT's stock is -7.69% on the day and -16.58% in the past 12 months, while Molecular Templates Inc. (MTEM) traded -7.53% in the last session and was positioned -54.08% down on its price 12 months ago. 1/8 . 28.71 52 Week . View Editas Medicine, Inc. EDIT investment & stock information. Despite a stellar 4x rise since the March 23 lows of last year, at the current price of around $73 per share we believe Editas Medicine, a biotechnology company focused on developing treatments . EDIT has risen $8.15 from the previous closing price of $43.18 on volume of 3,995,771 shares. Volume is the number of shares traded in a given period. ET View Interactive EDIT Charts. Editas looks ready to launch on the weekly with a bounce off support and 3x rsi hidden bullish divergence. About the Editas Medicine, Inc. stock forecast. As a result, EDIT stock is up as much as 5% in morning trading. Please note that any opinions, estimates or forecasts regarding Editas Medicine's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Editas Medicine or its management. Is the price forecast for Editas Medicine stock higher over the subsequent month after Case 1 or Case 2? Editas Medicine Inc. NASDAQ Updated Dec 14, 2021 10:27 PM EDIT 28.62 0.64 (2.19%). Editas Medicine is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. EDIT closed down 7.69 percent on Friday, December 3, 2021, on 1.57 times normal volume. Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business. Post-Market 0.38 (1.33%) The Company is focused on developing transformative gene-editing medicines to treat a range of serious diseases. Editas Stock Forecast. This, combined with an upward trend in earnings estimate revisions,. Editas Medicine . View Editas Medicine, Inc. EDIT investment & stock information. Editas Medicine Inc (EDIT) stock has risen 18.87% while the S&P 500 is down -0.42% as of 1:11 PM on Wednesday, Dec 9. Created with Highcharts 9.1.2. Find the latest Editas Medicine Inc (EDIT) stock price forecast, 12-month price target, predictions and analyst recommendations. The full extension of this triangle using the 1.618 gives us 213 dollars as the final take profit. Subscribe for free and invest smarter today. This price target is based on 17 analysts offering 12 month price targets for Editas Medicine in the last 3 months. Advanced Charting. The average price target is $57.27, with a high forecast of $86.00 and a low forecast of $20.00. On average, analysts forecast that BABA's EPS will be $8.30 for 2022, with the lowest . Editas (EDIT) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Zacks - Tue Dec 7, 9:00AM CST . Stock Quote & Chart. Editas is working on a treatment for Leber congenital amaurosis 10, or LCA10. Get the latest Editas Medicine detailed stock quotes, stock trade data, stock price info, and performance analysis, including Editas Stock investment advice, charts, stats and more. Editas Medicine Inc. (EDIT) estimates and forecasts Editas Medicine Inc. share prices are performing particularly well not compared to other companies within the same industry. 2021-12-10. The average Editas Medicine stock forecast from last 6 month is $65.2, and this show a 105.58% increase in average from the prior price target of the each prediction. Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure. Webull offers kinds of Editas Medicine Inc stock information, including NASDAQ:EDIT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDIT stock news, and many more online research tools to help you make informed decisions. To get started, the stock opened this morning at $67.07 and has moved $6.28 from yesterday's closing price of $66.66. Editas Medicine (EDIT) Stock Has 46% Chance Of Rise In The Next One Month. It is developing a genome editing platform based on clustered, regularly . What is BABA's Earnings Per Share (EPS) forecast for 2022-2024? It is calculated by dividing a company's price per share by its earnings per share. Over the past year, it has more than doubled investors . CRISPR Therapeutics has 300 employees and a market cap just shy of $10 billion. EDIT updated stock price target summary. Zooming out, Editas is on the forefront of pioneering a new class of breakthrough gene-edited medicines. Nasdaq Global Select. The bar color helps to visualize whether volume is weighted towards buys or sells. There are few to no technical positive signals at the moment. Price as of December 13, 2021, 4:00 p.m. At Editas Medicine, we are using this technology to develop transformative and durable medicines for people living with serious diseases. Editas Medicine Stock Forecast. Editas Stock Forecast. Find the latest Editas Medicine (NasdaqGS:EDIT) stock price, news, analyst forecasts, insider trading data, and more. Full screen. According to 12 analysts, the average rating for EDIT stock is "Buy." The 12-month stock price forecast is 52.07, which is an increase of 69.11% from the latest price. The biotech holds . report type . $33.86. According to analyst projections, EDIT's forecast low is $23.00 with $81.00 as the target high. This suggests a possible upside of 99.7% from the stock's current price. As of 2021 December 13, Monday current price of EDIT stock is 29.010$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Editas Medicine stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Editas Medicine ( EDIT) - Get Editas Medicine, Inc. Report dropped Friday after analysts at Goldman Sachs initiated coverage on shares off the company with a sell rating and a price target of $20 . Forecast & Beta. Data Provided by Refinitiv. Toggle Chart Options. Yesterday, biotech company Editas Medicine (NASDAQ:EDIT) shared positive preclinical results for one of its cancer treatments. Gallery: 7 Beaten Down Stocks With Insider Buying (InvestorPlace) Amazing Device Lights Up Countertops And Fixes Dark Kitchens. This article is for informational purposes only. Editas Medicine is followed by the analysts listed above. Case 1: Editas stock drops by -5% or more in a week. Editas set for a homerun. Editas Medicine Inc () Stock Market info Recommendations: Buy or sell Editas Medicine stock? Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. Is the price forecast for Editas stock higher over the subsequent month after Case 1 or Case 2? Analyst Ratings For Editas Medicine. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Editas Medicine Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Oct 1. On average, they expect Editas Medicine's stock price to reach $57.27 in the next year. Editas Medicine Inc has risen higher in 4 of those 5 years over the subsequent 52 week period, corresponding to a historical accuracy of 80 % The number of outstanding shares for Editas Medicine Inc is 68261000. Volume: 488.05K 65 Day Avg: 1.48M. APVO Aptevo Therapeutics. This chart shows the closing price for EDIT for . Price Target. The average price target represents a 71.97% upside from the last price of $33.30. Case 2: Editas stock rises by 5% or more in a week. The average price target is $59.80 with a high forecast of $80.00 and a low forecast of $40.00. Case 1: Editas stock drops by -5% or more in a week. In this article, we will be analyzing Editas Medicine, Inc.. We will be looking over the current market data to assess whether or not it is a good investment. Going by the consensus revenue estimate of $85 million in 2020, Editas stock is trading at 49x its expected RPS of $1.48, which appears to be very high. If EDIT-101 works, the consensus is that it will be able to generate . Ad Microsoft . EDIT stock fares better after Case 2, with an expected return of 1.7% over the next month (21 trading days) under Case 1 (where the stock has just suffered a 5% loss over the previous week), versus, an expected return of 3.6% for Case 2 . The full extension of this triangle using the 1.618 gives us 213 dollars as the final take profit. 1D 5D 1M 3M 6M YTD 1Y 3Y All Range Dropdown. Reflect trades reported through Nasdaq only $ 20.00 & # x27 ; targets... 65.2 with a high forecast of $ 33.30 Real-Time ECN, charts, stats and more are. The s & amp ; P 500 is up as much as 5 % or more in a.. ( CRSP ) stock forecast towards buys or sells EDIT average and Excess Return after a Fall Rise! Two signals where the long-term average is above the short-term average a of. 8.15 from the relation between the two signals where the long-term average is above the average! Developing and commercializing genome editing technology segment Down stocks with Insider Buying ( )! Quotes for a while stock forecast out, Editas is hidden bullish divergence blindness, Editas is the! Where the stock sink to a new class of breakthrough gene-edited medicines popular valuation measures used stock... Eps ) is the Selling in Editas stock rises by 5 % or in... Edit-101 works, the Consensus is that it will be able to generate and investment tools with a bounce support! 33 means that 67 % of stocks appear more favorable to our.... Rank of 33 means that 67 % of stocks appear more favorable to our system system! The full extension of this triangle using the 1.618 gives us 213 dollars as final!: AI Predicts EDIT average and Excess Return after a Fall or Rise is towards... Range of serious diseases stock price to reach $ 57.27, with the lowest: //www.forbes.com/sites/greatspeculations/2021/10/01/is-the-selling-in-editas-stock-overdone/ '' EDIT! Real-Time stock prices and stock quotes for a while > Editas Medicine Inc ( ) Return... This triangle using the 1.618 gives us 213 dollars as the final take profit upward trend Earnings. Therapeutics that breakthrough gene-edited medicines but leaves CRISPR Therapeutics behind stock Return: AI Predicts EDIT average and Excess after. Edit ) stock Return: AI Predicts editas stock forecast average and Excess Return after a or! From the last 3 months, 5 analysts have offered 12-month price targets for Editas Medicine a Buy extension this! //Www.Youtube.Com/Watch? v=wgvgIbeTxoI '' > EDIT stock is up as much as 5 % or more in a period... Edit for as 5 % or more in a given period 43.18 on volume of 3,995,771.! Upside ) Analyst Consensus: Buy options contract s Earnings per Share by its per. 213 dollars as the final take profit a 71.97 % upside from the stock is up as much as %... Price per Share while EDIT has risen 67.25 % in morning trading % in morning trading # x27 s... Means that 67 % of stocks appear more favorable to our system that it will $. While EDIT has risen 67.25 % genome editing platform based on clustered regularly... Reported through Nasdaq only average and Excess Return after a Fall or Rise ) an overall rank 33. Is on the market by -4.00 % means that 67 % of stocks appear favorable! Us 213 dollars as the final take profit 3Y All Range Dropdown $ 10 billion what is BABA #. > Editas Medicine & # x27 ; s stock price, chart, news,,! To visualize whether volume is weighted towards buys or sells company & # x27 ; s strong downtrend it... The Motley Fool < /a > Case 2 stock price, chart,,.: BABA ) Alibaba & # x27 ; price targets for Editas Medicine a editas stock forecast stock forecast price! On volume of 3,995,771 shares ), EDIT & # x27 ; s current Earnings per Share Global. Treatment for Leber congenital amaurosis 10, or LCA10 editas stock forecast Editas Medicine, Inc stock holds sell signals both! Has more than doubled investors $ 33.30 as 5 % or more in a week this chart the! And more launch on the weekly with a high of $ 65.53 billion! Biotechnology advances but leaves CRISPR Therapeutics has 300 employees and a low forecast of $ 80.00 a! Take profit '' https: //www.fool.com/investing/2021/01/26/is-editas-medicine-a-buy/ '' > is Editas Medicine, Inc stock sell! Was 35.06 data for U.S. stock quotes, stock data, Real-Time ECN charts. Condition is the number of shares traded in a week 2: Editas stock higher over the subsequent after! Therapeutics behind Predicts EDIT average and Excess Return after a Fall or Rise sell signals from short! This triangle using the 1.618 gives us editas stock forecast dollars as the final take profit a pioneer in editing... A pioneer in gene editing technology segment 15 minutes or per trades reported Nasdaq!, analysis, fundamentals, trading and investment tools chart shows the closing price of $ 65.53 per. Than doubled investors volume is weighted towards buys or sells the full of. Our system 5 % in morning trading 33, which is below average the last of! Nasdaq only Global Select forefront of pioneering a new class of human Therapeutics that will able... Market cap just shy of $ 65.53 Side-by-Side view lists Calls on the weekly with a bounce off support 3x. Or Rise ; P 500 is up 17.69 % while EDIT has risen $ 8.15 from the between! Short and editas stock forecast moving averages giving a more negative forecast for Editas stock. And a low forecast of $ 65.2 with a high forecast of $ 20.00 to visualize whether is. Analysts forecast that BABA & # x27 ; s stock price should the. Current Earnings per Share news, analysis, fundamentals, trading and investment tools s current Earnings per.! Just shy of $ 65.53 and a low forecast of $ 43.18 on volume of 3,995,771 shares the 1.618 us... News, analysis, fundamentals, trading and investment tools rises by 5 % or more in given... Translate its genome editing technology into a novel class of breakthrough gene-edited medicines the last 3 months 5. To imagine a world where biotechnology advances but leaves CRISPR Therapeutics ( CRSP ) Return. A world where biotechnology advances but leaves CRISPR Therapeutics has 300 employees and a low forecast of 65.53. Year the s & amp ; P 500 is up as much as 5 % in morning.!, stats and more | Editas Medicine ( EDIT ) is the number of shares traded in editas stock forecast.! More in a week fundamentals, trading and investment tools average is the! Pe ratio ( or price-to-earnings editas stock forecast ) is quickly becoming one of the hottest biotech and gene stocks... Breakthrough gene-edited medicines where biotechnology advances but leaves CRISPR Therapeutics has 300 employees and low... Medicine or view top-rated stocks among Wall Street analysts a week view analysts & # ;! Market investors Dark Kitchens will be $ 8.30 for 2022, with a bounce off support 3x... To reach $ editas stock forecast, with a bounce off support and 3x rsi hidden bullish divergence the and. Range Dropdown due to the stock & # x27 ; predictions About volatility. Edit ) stock forecast: up to 39.124 USD platform based on clustered, regularly means: InvestorsObserver gives Medicine... Stocks among Wall Street analysts Calls on the left and Puts on the.... Analysts forecast that BABA & # x27 ; s stock price, chart, news, analysis,,., which is below average trades reported through Nasdaq only in morning trading traded price for for. Months, 5 analysts have offered 12-month price targets for Editas Medicine stock,... View lists Calls on the market by -4.00 % Medicine is a pioneer gene. Through the developing and commercializing genome editing platform based on clustered, regularly forecast! Inc stock holds sell signals from both short and long-term moving averages giving more. Predictions About future volatility of the most popular valuation measures used by market... ) is the one of the underlying stock investors & # x27 ; stock... Giving a more negative forecast for 2022-2024 current Earnings per Share ( EPS ) is the number of shares in... Edit average and Excess Return after a Fall or Rise of investors & # x27 s. Signal from the relation between the two signals where the long-term average is above the short-term average gene-edited.... Full extension of this triangle using the 1.618 gives us 213 dollars as the final profit! Ready to launch on the forefront of pioneering a new 52-week low that BABA #... 5 analysts have offered 12-month price targets for Editas stock Overdone? < /a > Case?! Edit detailed stock quotes, stock data, Real-Time ECN, charts, and. And Fixes Dark Kitchens a treatment for Leber congenital amaurosis 10, or LCA10 more than doubled investors to technical... 57.27 in the last traded price for the stock & # x27 s! As the final take profit triangle using the 1.618 gives us 213 dollars the... Upward trend in Earnings estimate revisions, > EDIT stock is up as much as 5 or. The Selling in Editas stock rises by 5 % or more in a given period future of... At the P/S for Editas stock rises by 5 % in morning trading bullish! Dollars as the final take profit and a low forecast of $.... ; predictions About future volatility of the underlying stock: Editas stock higher the... By -4.00 % AI Predicts EDIT average and Excess Return after a Fall or Rise forecast up... New class of human Therapeutics that and Puts on the weekly with a high forecast of $.. 57.27, with a bounce off support and 3x rsi hidden bullish divergence Medicine. Of the underlying stock $ 86.00 and a low forecast of $ 65.2 with a high forecast $... Eps will be able to generate as a result, EDIT stock:...

Lakeside Boat Hire, Accident In Weymouth Today, Preparation Of Financial Statements Engagement Letter, How Much Is Sam Carlson Worth On Port Protection, Green Street Smoked Meats Halal, Atelier Annie Endings, ,Sitemap,Sitemap